Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 43 | -21 | 8 | 28 | 413 |
| Cost of Goods | 47 | -29 | 14 | 74 | 370 |
| Gross Profit | -4 | 8 | -5 | -46 | 42 |
| Operating Expenses | 669 | 681 | 538 | 230 | 1,204 |
| Operating Income | -673 | -674 | -543 | -275 | -1,161 |
| Interest Expense | 58 | 10 | 72 | 105 | 59 |
| Other Income | 21 | 29 | 8 | 32 | 1 |
| Pre-tax Income | -711 | -655 | -607 | -349 | -1,218 |
| Income Tax | 4 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -715 | -547 | -607 | -349 | -1,218 |
| Net Income | $-715 | $-547 | $-607 | $-349 | $-1,218 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-634 | $-612 | $-499 | $-197 | $-1,112 |